New Consumer & Healthcare Provider Guides for Rheumatoid Arthritis Medicines

New guides that compare the benefits, risks, and price estimates of rheumatoid arthritis drugs are now available from the Effective Health Care program of the Agency for Healthcare Research and Quality (AHRQ. The guide for consumers, Rheumatoid Arthritis Medicines, A Guide for Adults, and the guide for clinicians, Choosing Medications for Rheumatoid Arthritis, draw on information in a recent AHRQ-funded comparative effectiveness review. The rheumatoid arthritis guides review three classes of available medicines: synthetic disease-modifying antirheumatic drugs (DMARDs), biologic DMARDs, and corticosteroids. These publications represent AHRQ’s eighth comparative effectiveness report translated into plain language guides. Other topics include treatments for high blood pressure, depression, diabetes, osteoarthritis, renal artery stenosis, and gastroesophageal reflux disease (GERD). All of the guides can be viewed at the Effective Health Care Web site. Print copies are available by e-mailing to Organizations are encouraged to post links to the guides on Web sites or in newsletters.